Paul Visintainer to Transfusion Reaction
This is a "connection" page, showing publications Paul Visintainer has written about Transfusion Reaction.
Connection Strength
0.391
-
Edens C, Haass KA, Cumming M, Osinski A, O'Hearn L, Passanisi K, Eaton L, Visintainer P, Savinkina A, Kuehnert MJ, Basavaraju SV, Andrzejewski C. Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States. Transfusion. 2019 02; 59(2):524-533.
Score: 0.148
-
Zubairi H, Visintainer P, Fleming J, Richardson M, Singh R. Lead exposure in preterm infants receiving red blood cell transfusions. Pediatr Res. 2015 Jun; 77(6):814-8.
Score: 0.114
-
Andrzejewski C, Popovsky MA, Stec TC, Provencher J, O'Hearn L, Visintainer P, Steingrub J. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects? Transfusion. 2012 Nov; 52(11):2310-20.
Score: 0.093
-
Andrzejewski C, O'Hearn L, Rock J, Passanisi K, Eaton L, Knee A, Edappallath S, Merola M, Cloutier D, Visintainer P, Johari V. Enhancing hemotherapy safety through pertinent diagnostic testing and electronic "provisional diagnosis" reporting: expanding roles for blood bank technologists in biovigilance and patient safety. Transfusion. 2018 07; 58(7):1708-1717.
Score: 0.036